Top news in December: Dental health and CVD risk; expanded bempedoic acid indication; more
Click Here to Manage Email Alerts
Healio and Cardiology Today have compiled a list of the most-read news in cardiology in December 2023.
Readers were most interested in the association between poor dental health and risk for stroke; findings from the 2023 Global Burden of Disease special report on CVD; the FDA approval of an expanded indication for bempedoic acid; and more.
Image: Adobe Stock
Presence of decayed, filled, missing teeth linked to stroke risk
The presence of decayed, filled and missing teeth was associated with increased risk for stroke and death, especially among Black participants vs. white participants in the ARIC study, according to a subanalysis published in Stroke. Read more
Blood pressure remains largest contributor to global CVD; mortality on the rise
Global CV mortality and the prevalence of important cardiometabolic risk factors increased through 2022, with high BP remaining the strongest contributor, according to the 2023 update to the Global Burden of Disease special report on CVD. Read more
No difference in most long-term morbidity, mortality outcomes for three BP medications
In adults with hypertension and at least one CHD risk factor followed for up to 23 years, three antihypertensive medications did not differ in CVD mortality, according to long-term results of the ALLHAT trial. Read more
FDA approves expanded indications for bempedoic acid and combination tablet
Esperion announced the FDA granted an updated indication for bempedoic acid and bempedoic acid plus ezetimibe for the treatment of primary hyperlipidemia in eligible patients with genetic hyperlipidemia or atherosclerotic CVD. Read more
X-rays and the evolving standard of care for hospital staff
In this commentary, Ulrika Birgersdotter-Green, MD, discusses how standards of care have changed for interventional cardiologists, electrophysiologists and others who work daily with X-ray machines. Read more
Omega-3 fatty acid intake may lower CV risk in those with family history of heart disease
Higher intake of omega-3 polyunsaturated fatty acids, or omega-3s, may reduce risk for heart disease in those with a family history of CVD, according to data published in Circulation. Read more
FDA approves first pulsed field AF ablation system
Medtronic announced the FDA approved its pulsed field ablation system for treatment of both paroxysmal and persistent atrial fibrillation via pulmonary vein isolation. Read more
Incidence of sudden cardiac death among college athletes declined in recent years
The incidence of sudden cardiac death among National Collegiate Athletic Association athletes decreased over the past 2 decades, researchers reported at the American Heart Association Scientific Sessions. Read more
Use of assisted reproductive technologies may raise CVD risks
Women with a history of infertility who use assisted reproductive technologies may have increased risk for CVDs, such as preeclampsia, stroke and heart failure, according to a presenter. Read more
Two post-approval outcome trials of anti-hyperkalemia drug stopped for logistical reasons
AstraZeneca announced that two post-approval randomized heart- and kidney-related outcome studies of its anti-hyperkalemia drug have been stopped due to slow enrollment and low event rates. Read more
Collapse
Healio Coverage
Click Here to Manage Email Alerts